Q1 2021 Holdings
Filed 2021-05-14 | 148 holdings | $781.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $295.9M | 850,000 | 37.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $123.9M | 450,000 | 15.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $105.9M | 750,000 | 13.6% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $98.3M | 900,000 | 12.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $39.9M | 1,646,517 | 5.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $38.7M | 525,000 | 5.0% |
| Coupang Inc(CPNG) | CL A | 22266T109 | $19.7M | 400,000 | 2.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $15.4M | 250,000 | 2.0% |
| Adagene Inc(ADAG) | ADS | 005329107 | $14.4M | 800,000 | 1.8% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $13.0M | 1,000,000 | 1.7% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $6.9M | 750,000 | 0.9% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $4.2M | 100,000 | 0.5% |
| WW Intl Inc(WW6) | COM | 98262P101 | $463.5K | 14,818,300 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $417.8K | 71,178,364 | 0.1% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $279.5K | 5,588,366 | 0.0% |
| Citigroup Inc(C)Call | COM NEW | 172967424 | $218.3K | 3,000,000 | 0.0% |
| General Mtrs Co(GM)Call | COM | 37045V100 | $201.1K | 3,500,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $189.9K | 1,400,000 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $129.4K | 4,883,791 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $124.2K | 725,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $115.1K | 1,819,186 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $107.2K | 1,300,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $101.3K | 2,000,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $86.3K | 1,125,000 | 0.0% |
| Ford MTR Co del(F)Call | COM | 345370860 | $85.8K | 7,000,000 | 0.0% |
| Intel Corp(INTC)Call | COM | 458140100 | $83.2K | 1,300,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $80.1K | 2,814,191 | 0.0% |
| BK of America Corp(BAC)Call | COM | 060505104 | $77.4K | 2,000,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $72.3K | 1,500,000 | 0.0% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $67.8K | 500,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY)Call | COM | 110122108 | $63.1K | 1,000,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $60.8K | 797,445 | 0.0% |
| Allovir Inc | COM | 019818103 | $54.4K | 2,323,371 | 0.0% |
| Intel Corp(INTC) | COM | 458140100 | $51.2K | 800,000 | 0.0% |
| Alcoa Corp(AA)Call | COM | 013872106 | $48.7K | 1,500,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $48.7K | 650,000 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $43.8K | 1,549,513 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $38.6K | 1,317,954 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $38.5K | 500,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $38.4K | 750,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $37.4K | 1,094,047 | 0.0% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $37.3K | 2,255,375 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $37.1K | 3,750,000 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $36.4K | 750,000 | 0.0% |
| Broadcom Inc(AVGO) | COM | 11135F101 | $34.8K | 75,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $34.3K | 2,500,000 | 0.0% |
| KE Hldgs Inc(BEKE) | SPONSORED ADS | 482497104 | $34.2K | 600,000 | 0.0% |
| Freeport-Mcmoran Inc(FCX)Call | CL B | 35671D857 | $32.9K | 1,000,000 | 0.0% |
| Avis Budget Group(CAR) | COM | 053774105 | $32.6K | 450,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $29.6K | 312,700 | 0.0% |